Prof. Farhad Hafezi
February 16, 2009
From Keratoconus Global, the patient organization, to Farhad Hafezi, for his work on CXL technology.
The very first report on the use of CXL to halt ectasia that was activated by pregnancy
Arq Bras Oftalmol. Read here.
The first television report on cross-linking for progressive keratoconus in Switzerland.
First article on Corneal Cross-Linking in the Swiss Popular Press
Discovery of the demarcation line in cross-linking
Interview on Corneal Cross-Linking in 2005
